The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open-label, phase 2 study evaluating abemaciclib in combination with irinotecan and temozolomide in participants with relapsed or refractory Ewing sarcoma.
 
Gertjan VAN HAL
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
 
Alba Rubio-San-Simón
Consulting or Advisory Role - EUSA Pharma
Research Funding - Lilly O. (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Roche
 
Chitose Ogawa
Honoraria - Chugai Pharma
Consulting or Advisory Role - Kyowa Kirin Co., Ltd.; Pfizer
Speakers' Bureau - Ohara Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)
 
Antonio Juan-Ribelles
Research Funding - Lilly O. (Inst)
 
Holly Knoderer
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
 
Jeremy Howard Lewin
Consulting or Advisory Role - Bayer (Inst)